Nephrology
Episodes 33-47 of 47
Jonathan Barratt, PhD
Donald E. Kohan, MD, PhD
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Antoine Lanot, MD, PhD
Mario Cozzolino, MD, PhD
Jan T. Kielstein, MD, FASN, FERA
David Jayne, MD
Annette Bruchfeld, MD, PhD
- KDIGO Conversations in Nephrology
Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients
Vladimir Tesar, MD
David Jayne, MD
- KDIGO Conversations in Nephrology
Challenges in the Early Diagnosis of AAV
Vladimir Tesar, MD
Duvuru Geetha, MD
- KDIGO Conversations in Nephrology
Is There Still Any Role for Plasma Exchange in AAV?
Vladimir Tesar, MD
Michael Walsh, MD
- KDIGO Conversations in Nephrology
Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI
Marlies Ostermann, MD
Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP
- KDIGO Conversations in Nephrology
Best Practices in Fluid Management During CKRT
Marlies Ostermann, MD
Javier Neyra, MD, MSCS
- KDIGO Conversations in Nephrology
The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients
Marlies Ostermann, MD
Rinaldo Bellomo, MBBS, MD, FRACP
- Global Heart Failure Academy
AFFIRM-AHF: Key Takeaways
Ewa A. Jankowska, MD, PhD, FESC
- Global Heart Failure Academy
Late-breaking First Response on AFFIRM-AHF
Stefan D. Anker, MD, PhD
Javed Butler
Ewa A. Jankowska, MD, PhD, FESC
Josep Comin-Colet, MD, PhD
- Global Heart Failure Academy
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
Mikhail Kosiborod, MD
- Global Heart Failure Academy
Balancing RAASi Therapy and Potassium: Understanding How it Works
- Global Heart Failure Academy
Mechanisms in Heart Failure: Why Iron Deficiency Matters
- Previous
- Next